VentureMed Group, Inc. is a commercial-stage medical device company that develops and markets cost-effective interventional devices to improve the treatment of peripheral artery disease. The Company's innovative product platforms are designed to improve clinical outcomes and reduce procedural costs. VMG's lead platform is the FLEX Scoring Catheter. FLEX has the ability to treat the complete range of peripheral vessel diameters and lesion lengths and has been described as a safe, efficient and intuitive tool for the treatment of PAD by interventionalists. FLEX is FDA approved and has CE Mark approval and is available for sale and distribution in the United States and Europe.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/16/17 | $15,000,000 | Series B |
Endeavor Vision RiverVest Venture Partners | undisclosed |
